Education
About Us
Working with TipRanks
Follow Us
Global Health Limited (IN:MEDANTA)
:MEDANTA
RESEARCH TOOLSreports
MEDANTA Analyst Ratings
Hold
1 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MEDANTA Stock 12 Month Forecast
Average Price Target
₹1,172.50
▼(-11.55% Downside)
| Highest Price Target₹1,380 | Average Price Target₹1,173 | Lowest Price Target₹965.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
₹1,499
Buy
13.08%
Upside
Reiterated
07/18/25
Global Health Limited demonstrates robust financial performance with strong revenue and profit growth, supported by prudent leverage and a solid balance sheet. However, the overbought technical indicators and high P/E ratio suggest potential risks of a price correction and overvaluation. The lack of a dividend yield further impacts its valuation attractiveness. Overall, while the company is financially sound, investors should approach with caution due to current valuation levels and technical signals.
HSBC
₹855→₹965
Sell
-27.20%
Downside
Reiterated
07/17/25
Jefferies
₹1,360→₹1,380
Buy
4.10%
Upside
Reiterated
05/18/25
J.P. Morgan
₹1,020→₹1,240
Hold
-6.46%
Downside
Upgraded
02/06/25
Kotak Mahindra
₹1,175→₹1,285
Buy
-3.06%
Downside
Reiterated
02/06/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
₹1,499
Buy
13.08%
Upside
Reiterated
07/18/25
Global Health Limited demonstrates robust financial performance with strong revenue and profit growth, supported by prudent leverage and a solid balance sheet. However, the overbought technical indicators and high P/E ratio suggest potential risks of a price correction and overvaluation. The lack of a dividend yield further impacts its valuation attractiveness. Overall, while the company is financially sound, investors should approach with caution due to current valuation levels and technical signals.
HSBC
₹855→₹965
Sell
-27.20%
Downside
Reiterated
07/17/25
Jefferies
₹1,360→₹1,380
Buy
4.10%
Upside
Reiterated
05/18/25
J.P. Morgan
₹1,020→₹1,240
Hold
-6.46%
Downside
Upgraded
02/06/25
Kotak Mahindra
₹1,175→₹1,285
Buy
-3.06%
Downside
Reiterated
02/06/25
Best Analysts Covering Global Health Limited
1 Month
xxx
Success Rate
2/3 ratings generated profit
Average Return
-1.40%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -1.40% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
Average Return
-4.13%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -4.13% per trade.
1 Year
Success Rate
1/3 ratings generated profit
Average Return
-8.47%
reiterated a sell rating 23 days ago
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -8.47% per trade.
2 Years
xxx
Success Rate
1/3 ratings generated profit
Average Return
-8.47%
reiterated a xxx
rating 23 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -8.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MEDANTA Analyst Recommendation Trends
Rating
Dec 24
Feb 25
Jul 25
Strong Buy
0
0
0
Buy
1
3
10
Hold
0
1
1
Sell
0
1
2
Strong Sell
0
0
0
total
1
5
13
Each month's total comprises the sum of three months' worth of ratings.
MEDANTA Financial Forecast
MEDANTA Stock Forecast FAQ
What is IN:MEDANTA’s average 12-month price target, according to analysts?
Based on analyst ratings, Global Health Limited’s 12-month average price target is 1,172.50.
What is IN:MEDANTA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:MEDANTA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Global Health Limited a Buy, Sell or Hold?
Global Health Limited has a consensus rating of Hold, which is based on 1 buy ratings, 0 hold ratings and 1 sell ratings.
What is Global Health Limited’s share price target?
The average share price target for Global Health Limited is 1,172.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,380.00 ,and the lowest forecast is ₹965.00. The average share price target represents -11.55% Decrease from the current price of ₹1,325.6.
The highest analyst share price target is ₹1,380.00 ,and the lowest forecast is ₹965.00. The average share price target represents -11.55% Decrease from the current price of ₹1,325.6.
What do analysts say about Global Health Limited?
Global Health Limited’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Global Health Limited?
To buy shares of IN:MEDANTA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.